This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2024 Jun 13;143(24):2441-2442.

doi: 10.1182/blood.2024024592.

Tumor burden in ZUMA-7: less is more

Eli P Darnell^{1

2}, Marcela V Maus^{1

2}

Affiliations

PMID: 38869918
DOI: 10.1182/blood.2024024592

Free article

Editorial

Tumor burden in ZUMA-7: less is more

Eli P Darnell et al. Blood. 2024.

Free article

. 2024 Jun 13;143(24):2441-2442.

doi: 10.1182/blood.2024024592.

Authors

Eli P Darnell^{1

2}, Marcela V Maus^{1

2}

Affiliations

¹ Mass General Cancer Center.
² Harvard Medical School.

PMID: 38869918
DOI: 10.1182/blood.2024024592

No abstract available

PubMed Disclaimer

Comment on

Axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume.
Locke FL, Oluwole OO, Kuruvilla J, Thieblemont C, Morschhauser F, Salles G, Rowe SP, Vardhanabhuti S, Winters J, Filosto S, To C, Cheng P, Schupp M, Korn R, Kersten MJ. Locke FL, et al. Blood. 2024 Jun 13;143(24):2464-2473. doi: 10.1182/blood.2023021620. Blood. 2024. PMID: 38557775 Free PMC article. Clinical Trial.

References

Publication types

Actions
Actions

MeSH terms

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems